Abbvie Inc (NYSE:ABBV)

107.16
BATS BZX Real-Time Price
As of 11:12am ET
 +0.01 / +0.01%
Today’s Change
79.11
Today|||52-Week Range
121.53
+0.01%
Year-to-Date
AbbVie (ABBV) Files for Skyrizi in Crohn's Disease With FDA
Sep 21 / Zacks.com - Paid Partner Content
ObsEva (OBSV) Files NDA for Linzagolix to Treat Uterine Fibroids
Sep 15 / Zacks.com - Paid Partner Content
Biogen's (BIIB) Lucentis BioSimilar Byooviz Gets FDA Approval
Sep 21 / Zacks.com - Paid Partner Content
Is AbbVie's 4.9% Dividend Yield Safe?
Sep 15 / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) Stock Moves -1.23%: What You Should Know
Sep 20 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know
Sep 14 / Zacks.com - Paid Partner Content
Sunflower Bank, N.A. Buys S&P 500 ETF TRUST ETF, Procter & Gamble Co, JPMorgan ...
Sep 20 / GuruFocus News - Paid Partner Content
REGENXBIO (RGNX) Stock Up on Collaboration Deal With AbbVie
Sep 14 / Zacks.com - Paid Partner Content
Is AbbVie a Bad News Buy?
Sep 19 / MotleyFool.com - Paid Partner Content
DiaMedica (DMAC) Initiates Pivotal Ischemic Stroke Study
Sep 14 / Zacks.com - Paid Partner Content
Calamos Growth and Income Portfolio Buys AbbVie Inc, Sells Fortive Corp, Vertex Pharmaceuticals ...
Sep 18 / GuruFocus News - Paid Partner Content
AbbVie (ABBV) to Co-Develop Regenxbio Eye Disease Gene Therapy
Sep 14 / Zacks.com - Paid Partner Content
AbbVie's Pain Is Sanofi's and Regeneron's Gain
Sep 18 / MotleyFool.com - Paid Partner Content
5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal
Sep 14 / Zacks.com - Paid Partner Content
5 Berkshire Hathaway Stocks in Downtrends
Sep 17 / GuruFocus News - Paid Partner Content
Why Regenxbio Stock Is Way Up Today
Sep 13 / MotleyFool.com - Paid Partner Content
4 Berkshire Hathaway Stocks in Downtrends
Sep 17 / GuruFocus News - Paid Partner Content
These Promising Clinical Results Could Be Huge for Amgen Investors
Sep 11 / MotleyFool.com - Paid Partner Content
Why BeiGene's Shares Jumped on Friday
Sep 17 / MotleyFool.com - Paid Partner Content
3 Stocks to Watch in September
Sep 10 / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) Files for Rinvoq in Ulcerative Colitis in US & EU
Sep 17 / Zacks.com - Paid Partner Content
Why Shares of Johnson & Johnson Are Down 2% Today
Sep 09 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: ABBV's Deal With RGNX, LLY COVID Drug's Government Order Win
Sep 17 / Zacks.com - Paid Partner Content
Is Berkshire Hathaway Trading in its Stock Portfolio?
Sep 09 / Zacks.com - Paid Partner Content
2 Embarrassingly Cheap Dividend Stocks to Buy
Sep 16 / MotleyFool.com - Paid Partner Content
Could This Label Expansion Be a Blockbuster for AbbVie's Shareholders?
Sep 09 / MotleyFool.com - Paid Partner Content